Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong Province, China.
UPMC Eye Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Indian J Ophthalmol. 2022 Oct;70(10):3483-3489. doi: 10.4103/ijo.IJO_649_22.
This study aimed to evaluate the outcomes of astigmatic correction by single-step transepithelial photorefractive keratectomy (TransPRK) and femtosecond-assisted laser in-situ keratomileusis (Femto-LASIK) surgeries.
A total of 218 subjects received TransPRK or Femto-LASIK surgery for the treatment of myopia and astigmatism (-2.25 to -0.25 D). Refraction errors and uncorrected (UDVA) and corrected distance visual acuity (CDVA) were examined before and at 3 months after surgery. Astigmatism changes were assessed by vector analysis.
Preoperative parameters of the TransPRK group were similar to the Femto-LASIK group. UDVA and CDVA at 3 months were similar between both groups. Manifest refraction (MR) spherical equivalent in the TransPRK group (0 ± 0.20 D) was slightly lower compared with the Femto-LASIK group at 3 months (0.11 ± 0.25 D, P = 0.001). MR cylinder was -0.06 ± 0.19 D in the TransPRK group and -0.02 ± 0.15 D in the Femto-LASIK group at 3 months (P = 0.135). The index of success (IS) was 0.15 ± 0.36 in the TransPRK group and 0.06 ± 0.17 in the Femto-LASIK group (P = 0.125). The correction index (CI) was 1.03 ± 0.19 in the TransPRK group and 1.01 ± 0.11 in the Femto-LASIK group (P = 0.815).
For low to moderate myopic astigmatism, TransPRK provided a comparable astigmatic treatment effect as Femto-LASIK. Myopic astigmatism was both slightly overcorrected after TransPRK and Femto-LASIK surgeries.
本研究旨在评估单步经上皮准分子激光角膜切削术(TransPRK)和飞秒激光辅助原位角膜磨镶术(Femto-LASIK)治疗近视散光的效果。
共 218 例近视散光患者(-2.25 至-0.25 D)接受 TransPRK 或 Femto-LASIK 手术治疗。术前和术后 3 个月检查屈光度和未矫正(UDVA)及矫正远视力(CDVA)。用向量分析评估散光变化。
TransPRK 组术前参数与 Femto-LASIK 组相似。两组术后 3 个月 UDVA 和 CDVA 相似。TransPRK 组术后 3 个月的平均(球镜)等效折射(MRSE)(0±0.20 D)略低于 Femto-LASIK 组(0.11±0.25 D,P=0.001)。TransPRK 组术后 3 个月的 MR 柱镜为-0.06±0.19 D,Femto-LASIK 组为-0.02±0.15 D(P=0.135)。TransPRK 组的成功率指数(IS)为 0.15±0.36,Femto-LASIK 组为 0.06±0.17(P=0.125)。矫正指数(CI)在 TransPRK 组为 1.03±0.19,在 Femto-LASIK 组为 1.01±0.11(P=0.815)。
对于低中度近视散光,TransPRK 与 Femto-LASIK 提供了相当的散光治疗效果。TransPRK 和 Femto-LASIK 手术后近视散光均略有过矫。